Montelukast Prescribing at PHOENIX HEALTH GROUP
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
2,935
Total Quantity
85.4K
NHS Cost
£5.0K
vs National Avg
+328.6%
PHOENIX HEALTH GROUP prescribed 2,935 items of Montelukast over the last 12 months at a cost of £5,012 to the NHS. This is 328.6% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
257
Jul 2026
247
Jul 2026
254
Jul 2026
232
Jul 2026
239
Jul 2026
249
Jul 2026
238
Jul 2026
276
Jul 2026
240
Jul 2026
227
Jul 2026
236
Jul 2026
240
Prescribing Details
| Total Items | 2,935 |
|---|---|
| Total Quantity | 85,440 |
| Total NHS Cost | £5,012 |
| Presentations | 5 different forms |
| vs National Average | +328.6% |
Montelukast Prescribing Comparison
| This practice | 2,935 items |
|---|---|
| National average per practice | 685 items |
| Difference | +328.6% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.